Back to News

Not-So-Sweet Surprises for Allergy Sufferers

Published on

October 8, 2020

“How much is too much?”

This is a question asked fairly often in the context of allergen cross-contamination. We know that a Nutella is made from hazelnuts (these delicious morsels also go by the name “filbert”), so it’s no surprise to see the required “Contains hazelnuts” statement on the label. But when is it appropriate to say “may contain peanuts” or “manufactured on equipment that also processes soy”? And which of these statements may be required?

As a general rule, if one of the “Big Eight” allergens is included in a food as an ingredient, the U.S. Food and Drug Administration (FDA) requires a warning statement on the food’s package that begins with the word “Contains,” and states which allergen is present in the product. Food manufacturers know that avoiding allergen cross contamination is a part of Current Good Manufacturing Practice (cGMP). Yet, even the most comprehensive cleanout procedures may leave dangerous levels of residue behind. The FDA doesn’t have any requirements for statements – called “advisory statements” – intended to alert customers to some level of unintentional allergen residue resulting from cross-contamination.

Does the FDA tell us where to draw the line between warning statements and advisory statements? How much is too much? As it stands today, FDA doesn’t provide any quantitative guidance here for the Big Eight.

For now.

The agency recently published a study of a sampling of dark chocolate manufactured and sold in the U.S. bearing “dairy free” or similar claims, and found a number of products (approximately 10%) containing what FDA refers to as “potentially hazardous levels of undeclared milk.” It seems that there is a threshold level of allergen – at least for milk – that the FDA considers to be hazardous. However, the agency has yet to publish any “action level” or, conversely, “tolerance level,” leaving manufacturers ruminating over how best to label products that may contain an allergen.

The FDA has indicated its intent to continue to monitor the food industry for allergen levels in “allergen-free” products, and we will continue to monitor any action the FDA may take, including the possible establishment of tolerance levels.

If you have questions about how to label your food product, or any questions related to food manufacturing and sales, please contact me or anyone in the Barley Snyder Food & Agribusiness Industry Group for guidance. 


Related News

View More News
Press Release
April 13, 2026

Barley Snyder Named Central Penn Business Journal Legacy Business Honoree for Second Consecutive Year

For Immediate Release Lancaster, Pa. – As Barley Snyder celebrates 70 years of service, the firm has once again been named ...

Learn More
News Alert
February 23, 2026

FDA Signals Sweeping Shift Away from Petroleum‑Based Synthetic Food Dyes: New Labeling Flexibility and Reformulation Timelines

The U.S. Food and Drug Administration (FDA) has announced a series of regulatory policy changes that significantly tighten ov...

Learn More
News Alert
February 10, 2026

EPR Implementation in 2026: What Producers Need to Know from the NYC EPR Conference

Attorneys Catherine Begley and Hyo Jin (“Jinnie”) Lee recently attended the American Conference Institute’s EPR Think T...

Learn More

Other Upcoming Events

View All Upcoming Events
May
19
8:00 am
-
5:00 pm
event
Location

43rd Annual Employment Law Seminar

Learn More
Jun
04
7:30 am
-
12:00 pm
event
Location

Wake Up With Barley: A Morning on Real Estate 2026

Learn More

Get in Touch

Our attorneys, paralegals and staff look forward to hearing from you. Please reach out to let us know how we can help.

Get In Touch
RECOGNIZED IN
Super Lawyers
Best Law Firms US News
Best Lawyers